Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy-Reference-Cited by-同舟云学术

Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy

Published:2010-06 Issue:3 Volume:23 Page:200-207
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Blasi Francesco,Bonardi Daniela,Aliberti Stefano,Tarsia Paolo,Confalonieri Marco,Amir Omar,Carone Mauro,Di Marco Fabiano,Centanni Stefano,Guffanti Enrico

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference26 articles.

1. Respiratory infections complicating long-term tracheostomy: the implications of persistent Gram-negative tracheobronchial colonization;Niederman;Chest,1984

2. Respiratory tract colonization and infection in patients with chronic tracheostomy. A one-year study in patients living at home;Harlid;Am J Respir Crit Care Med,1996

3. Influence of clinical history on airways bacterial colonization in subjects with chronic tracheostomy;Lusuardi;Respir Med,2000

4. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection;Stockley;Thorax,1998

5. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis;Hill;Am J Med,2000

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrolide Use in Chronic Obstructive Pulmonary Disease;Progress in Inflammation Research;2024

2. Erythromycin Attenuates Hyperoxia Induced Lung Injury by Enhancing GSH Expression and Inhibiting Expression of Inflammatory Cytokines;Fetal and Pediatric Pathology;2023-06-21

3. Azithromycin ameliorated cigarette smoke-induced airway epithelial barrier dysfunction by activating Nrf2/GCL/GSH signaling pathway;Respiratory Research;2023-03-06

4. Azithromycin ameliorated cigarette smoke-induced airway epithelial barrier dysfunction by activating Nrf2/GCL/GSH signaling pathway;2022-12-05

5. Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection;European Journal of Pharmacology;2021-08